Shares of Cabot Corp (NYSE:CBT) have earned a consensus rating of “Buy” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $76.00.

Several equities research analysts recently commented on the company. TheStreet cut Cabot from a “b” rating to a “c+” rating in a report on Friday, October 19th. Zacks Investment Research cut Cabot from a “buy” rating to a “sell” rating in a report on Tuesday, October 16th. Loop Capital set a $134.00 price target on Cabot and gave the company a “buy” rating in a report on Saturday, July 28th. ValuEngine raised Cabot from a “strong sell” rating to a “sell” rating in a report on Friday. Finally, Barclays initiated coverage on Cabot in a report on Monday, October 8th. They issued an “overweight” rating and a $76.00 price target on the stock.

In other Cabot news, insider Nicholas S. Cross sold 16,000 shares of Cabot stock in a transaction that occurred on Tuesday, August 21st. The shares were sold at an average price of $65.86, for a total transaction of $1,053,760.00. Following the transaction, the insider now directly owns 48,597 shares in the company, valued at approximately $3,200,598.42. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Patrick M. Prevost sold 40,519 shares of Cabot stock in a transaction that occurred on Wednesday, August 22nd. The stock was sold at an average price of $65.65, for a total transaction of $2,660,072.35. Following the transaction, the director now owns 216,894 shares in the company, valued at $14,239,091.10. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CBT. Principal Financial Group Inc. grew its position in Cabot by 80.2% during the 1st quarter. Principal Financial Group Inc. now owns 481,555 shares of the specialty chemicals company’s stock worth $26,832,000 after purchasing an additional 214,334 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Cabot by 38.5% during the 2nd quarter. State of Alaska Department of Revenue now owns 6,650 shares of the specialty chemicals company’s stock valued at $410,000 after acquiring an additional 1,850 shares in the last quarter. Xact Kapitalforvaltning AB grew its holdings in shares of Cabot by 33.7% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 11,109 shares of the specialty chemicals company’s stock valued at $686,000 after acquiring an additional 2,800 shares in the last quarter. Oakbrook Investments LLC grew its holdings in shares of Cabot by 17.2% during the 2nd quarter. Oakbrook Investments LLC now owns 5,790 shares of the specialty chemicals company’s stock valued at $358,000 after acquiring an additional 850 shares in the last quarter. Finally, Foundry Partners LLC grew its holdings in shares of Cabot by 3.2% during the 2nd quarter. Foundry Partners LLC now owns 208,769 shares of the specialty chemicals company’s stock valued at $12,896,000 after acquiring an additional 6,463 shares in the last quarter. Hedge funds and other institutional investors own 85.40% of the company’s stock.

Shares of CBT stock opened at $49.35 on Friday. The company has a market capitalization of $3.04 billion, a price-to-earnings ratio of 12.25, a P/E/G ratio of 1.02 and a beta of 1.50. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.46 and a quick ratio of 0.92. Cabot has a 52 week low of $46.63 and a 52 week high of $68.63.

Cabot (NYSE:CBT) last announced its earnings results on Monday, November 5th. The specialty chemicals company reported $1.00 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.09 by ($0.09). Cabot had a positive return on equity of 18.82% and a negative net margin of 3.49%. The firm had revenue of $850.00 million for the quarter, compared to the consensus estimate of $856.76 million. During the same period in the previous year, the firm earned $0.91 EPS. Cabot’s revenue for the quarter was up 17.6% on a year-over-year basis. On average, analysts predict that Cabot will post 4.59 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 14th. Shareholders of record on Friday, November 30th will be issued a $0.33 dividend. The ex-dividend date is Thursday, November 29th. This represents a $1.32 annualized dividend and a dividend yield of 2.67%. Cabot’s dividend payout ratio is currently 32.75%.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods.

Featured Article: Discount Rate

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.